BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang S, Cheng J, Zhang R, Sun H, Zhang H, Lyu S, Duan W. Metabolic dysfunction-associated fatty liver disease and liver fibrosis: Prevalence and associated factors in the middle-aged and older US population. Hepatol Res 2021. [PMID: 34751487 DOI: 10.1111/hepr.13728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Duan S, Yang D, Xia H, Ren Z, Chen J, Yao S. Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults. Front Endocrinol 2022;13:1004855. [DOI: 10.3389/fendo.2022.1004855] [Reference Citation Analysis]
2 Maev IV, Andreev DN, Kucheryavyy YA. Metabolically associated fatty liver disease – a disease of the 21st century: A review. Consilium Medicum 2022;24:325-332. [DOI: 10.26442/20751753.2022.5.201532] [Reference Citation Analysis]
3 Maksimova E, Kliaritskaia I, Stilidi E, Grigorenko E, Moshko Y. Influence of changes in the intestinal microbiome on the course and progression of metabolically associated fatty liver disease. NAMJ 2022. [DOI: 10.56936/18290825-2022.16.2-38] [Reference Citation Analysis]